Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.

Sara Denicolò Vera Reinstadler Felix KellerStefanie ThöniSusanne EderHiddo J Lambers Heerspink László Rosivall Andrzej Więcek Patrick B Mark Paul Perco Johannes Leierer Andreas Kronbichler Herbert Oberacher Gert Mayer

Published in: Diabetologia (2024)

This analysis shows that non-adherence to cardiometabolic drug regimens is common in type 2 diabetes mellitus and negatively affects kidney and cardiovascular outcomes.

Keyphrases

adverse drug
healthcare
glycemic control
emergency department
adipose tissue
metabolic syndrome